首页|增强CT中病灶/肾皮质密度比值鉴别诊断肾透明细胞癌的价值

增强CT中病灶/肾皮质密度比值鉴别诊断肾透明细胞癌的价值

扫码查看
目的 探究增强CT中病灶/肾皮质密度比值在肾透明细胞癌(RCC)鉴别诊断中的应用。方法 选取2020年5月至2023年5月宣城市中心医院收治的100例RCC患者(RCC组)的临床资料开展回顾性分析,另选取本院同期治疗的50例肾嗜酸性细胞瘤(RO)患者(RO组)临床资料开展对照研究。比较两组增强CT各期(皮髓期、实质期、排泄期)病灶/肾皮质密度比值的差异,并通过受试者工作特征(ROC)曲线分析增强CT各期病灶/肾皮质密度比值诊断RCC的效能。按国际泌尿病理学会分级方法将RCC患者分为高级别组58例(Ⅲ级36例、Ⅳ级22例)、低级别42例(Ⅰ级10例、Ⅱ级32例)。比较不同分级程度RCC患者增强CT各期病灶/肾皮质密度比值的差异,分析增强CT各期病灶/肾皮质密度比值与病情分级程度的相关性。结果 两组皮髓期病灶/肾皮质密度比值>实质期病灶/肾皮质密度比值>排泄期病灶/肾皮质密度比值(均P<0。05),且RCC组皮髓期、实质期、排泄期病灶/肾皮质密度比值均高于RO组(均P<0。05)。ROC曲线分析结果显示,皮髓期、实质期、排泄期病灶/肾皮质密度比值诊断RCC的ROC曲线下面积(AUC)分别为0。817、0。870、0。773,联合数据诊断RCC的AUC为0。896,灵敏度为80。0%,特异度为90。0%。高级别组皮髓期、实质期、排泄期病灶/肾皮质密度比值均高于低级别组(均P<0。05)。Pearson相关分析显示,增强CT各期病灶/肾皮质密度比值均与分级程度呈正相关(r=0。319、0。498、0。311,P<0。05)。结论 RCC患者增强CT各期病灶/肾皮质密度比值均升高,均可作为诊断RCC的有效指标,联合诊断效能更好,且与分级程度密切相关,可用于临床评估。
Value of lesion/renal cortex density ratio in differential diagnosis of renal clear cell carcinoma with enhanced CT
Objective To explore the application of lesion/renal cortex density ratio in contrast-enhanced computed tomography(CT)in the differential diagnosis of renal clear cell carcinoma(RCC).Methods A retrospective analysis was conducted on the clinical data of 100 RCC patients(RCC group)admitted to the Xuancheng Central Hospital from May 2020 to May 2023.In addition,a control study was conducted on the clinical data of 50 renal eosinophilic cell carcinoma(RO)patients(RO group)treated in the same period at our hospital.We compared the differences in lesion/renal cortex density ratios between two groups of enhanced CT scans at different stages(cortical,parenchymal,and excretory),and analyzed the diagnostic efficacy of lesion/renal cortex density ratios in RCC using receiver operating characteristic(ROC)curves.According to the classification method of the International Society of Urology,RCC patients were divided into a high-grade group of 58 cases(Grade Ⅲ 36 cases,Grade Ⅳ 22 cases)and a low-grade group of 42 cases(Grade Ⅰ 10 cases,Grade Ⅱ 32 cases).The differences in the density ratio of lesions/renal cortex in different stages of enhanced CT were compared in RCC patients with different grading levels,and the correlation between the density ratio of lesions/renal cortex in different stages of enhanced CT and the degree of disease grading was analyzed.Results The ratio of lesions/renal cortex density in the corticomedullary phase was higher than that in the parenchymal phase,and the ratio of lesions/renal cortex density in the excretory phase(all P<0.05),and the ratio of lesions/renal cortex density in the corticomedullary phase,parenchymal phase,and excretory phase in the RCC group was higher than that in the RO group(all P<0.05).The ROC curve analysis results showed that the area under the ROC curve(AUC)for diagnosing RCC was 0.817,0.870,and 0.773 for lesions/renal cortex density ratio in the medullary,parenchymal,and excretory phases,respectively.The AUC for combined data diagnosis of RCC was 0.896,with a sensitivity of 80.0%and a specificity of 90.0%.The density ratio of lesions/renal cortex in the high-grade group was higher than that in the low-grade group during the cortical,parenchymal,and excretory phases(all P<0.05).Pearson correlation analysis showed that the ratio of lesion/renal cortex density in each phase of enhanced CT was positively correlated with the degree of grading(r=0.319,0.498,0.311,P<0.05).Conclusions The ratio of lesion/renal cortex density in all stages of enhanced CT in RCC patients increases,which can be used as an effective indicator for the diagnosis of RCC.The combined diagnostic efficacy is better and closely related to the degree of grading,which can be used for clinical evaluation.

Renal clear cell carcinomaTomography,X-ray computedKidney cortex

朱林、高勇、陶元元

展开 >

宣城市中心医院影像科,宣城 242000

肾透明细胞癌 体层摄影术,X线计算机 肾皮质

2024

中国医师杂志
中华医学会 湖南省医学会

中国医师杂志

CSTPCD
影响因子:0.876
ISSN:1008-1372
年,卷(期):2024.26(6)